Company Filing History:
Years Active: 2013-2014
Title: Inventor Spotlight: Sarah McFarland
Introduction
Sarah McFarland is an innovative inventor based in Sacramento, California. With a strong focus on biotechnological advancements, she has made significant contributions to the production of C4-dicarboxylic acids. Her groundbreaking work has resulted in two patents that showcase her expertise and dedication to the field of microbial biotechnology.
Latest Patents
Sarah McFarland holds two notable patents. The first one is titled "Recombinant microorganisms for production of C4-dicarboxylic acids." This patent describes host cells that possess carbonic anhydrase activity, enabling them to effectively produce C4-dicarboxylic acid through a defined cultivation process. The second patent, "C4 dicarboxylic acid production in filamentous fungi," details methods involving host cells with a polynucleotide encoding a C4 dicarboxylic acid transporter, aimed at enhancing the production of C4 dicarboxylic acids like malic acid. Both patents highlight her innovative approaches to microbial cultivation and acid production.
Career Highlights
Sarah McFarland is currently employed at Novozymes, Inc., a company renowned for its focus on enzyme production and biotechnology. Her work encompasses the development of sustainable methods that leverage recombinant microorganisms for industrial applications. Throughout her career, she has showcased a commitment to research and innovation that has the potential to reshape the production processes in various industries.
Collaborations
At Novozymes, Sarah collaborates with several talented colleagues, including Stephen H Brown and Sheryl Luttringer. These collaborative efforts enhance the research environment and foster the exchange of ideas, leading to the advancement of biotechnological innovation.
Conclusion
Sarah McFarland exemplifies the spirit of innovation in biotechnology through her patents and dedication to research. Her work has the potential to significantly impact the production of valuable compounds, ultimately contributing to a more sustainable future. Her achievements and collaborations within Novozymes, Inc. elevate her as a pivotal figure in the field of microbial biotechnology.